ArticleClinical and experimental immunology2013

Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study.

A Ruiz-Argüelles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.